299 related articles for article (PubMed ID: 20960504)
21. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group.
Biggar RJ; Frisch M; Goedert JJ
JAMA; 2000 Jul; 284(2):205-9. PubMed ID: 10889594
[TBL] [Abstract][Full Text] [Related]
22. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
23. Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.
Chen M; Jen I; Chen YH; Lin MW; Bhatia K; Sharp GB; Law MG; Arthur Chen YM
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):463-72. PubMed ID: 24583616
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
25. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
[TBL] [Abstract][Full Text] [Related]
26. Cancer as a cause of death among people with AIDS in the United States.
Simard EP; Engels EA
Clin Infect Dis; 2010 Oct; 51(8):957-62. PubMed ID: 20825305
[TBL] [Abstract][Full Text] [Related]
27. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
28. Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa.
Thomas JO
Semin Oncol; 2001 Apr; 28(2):198-206. PubMed ID: 11301383
[TBL] [Abstract][Full Text] [Related]
29. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.
Robbins HA; Shiels MS; Pfeiffer RM; Engels EA
AIDS; 2014 Mar; 28(6):881-90. PubMed ID: 24300545
[TBL] [Abstract][Full Text] [Related]
31. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Bahl S; Theis B; Nishri D; Marrett LD
Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
33. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
34. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
35. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
36. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
37. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of AIDS-related tumours in developed and developing countries.
Dal Maso L; Serraino D; Franceschi S
Eur J Cancer; 2001 Jul; 37(10):1188-201. PubMed ID: 11423251
[TBL] [Abstract][Full Text] [Related]
40. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
